Recall Register

Pharmacy Creations: FDA recalls

FDA enforcement events from 2013 to 2014; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Pharmacy Creations as the recalling firm in 3 events. The events have 7 product records. The recalls started from 2013 to 2014. All the events are drug recalls. By FDA enforcement events, Pharmacy Creations is number 1,113 of 1,628 firms that have a page. Events that Pharmacy Creations started: none in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

3 events, newest first.

FDA enforcement events of Pharmacy Creations
InitiatedProduct (first record)TypeClassRecordsStatus
5 Sep 2014Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.DrugClass I4Terminated
25 Jun 2014Ascorbic Acid 500 mg/mL Sterile Injection, 50 mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869.DrugClass I1Terminated
26 Aug 2013Lidocaine 1% PF Sterile Injection, 30 mL Single Dose Vial, Pharmacy Creations, Randolph, NJ.DrugClass II2Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Pharmacy Creations: events for each product type
TypeEvents
Drug3
Pharmacy Creations: events in each class
ClassEvents
Class I2
Class II1
Share of the events of the firm in Class I
67%
Share of all events on the register in Class I
18%
Events with the status Ongoing
0

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Pharmacy Creations, by the year that the recall started. The largest year is 2014, with 2 events.

Official channels

Cite this page

Recall Register. Pharmacy Creations: FDA recalls. https://recallregister.com/firm/pharmacy-creations/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
3 Nov 2026
State of the firm address
NJ

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Pharmacy Creations have?
Class I: 2 events. Class II: 1 event. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Pharmacy Creations?
FDA event 69184, which the firm started on 5 Sep 2014. The first product in the record is: Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.
How many FDA recalls of Pharmacy Creations have the status Ongoing?
No event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.